ALS
| 3 min read
COPD breakthroughs, billion-dollar biotech bets, brain-computer trials, and a historic push for women’s health led the news this week.
| 4 min read
HHS decisions on COVID-19 and flu vaccines, new therapies with encouraging results for depression and ALS, and more industry news this week.
| 6 min read
QurAlis researchers have developed QRL-101, a new drug candidate that targets overactive neurons to prevent cell death in ALS.
Page 1 of 1 - 3 Total Items
